Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
DLB Dolby Q1 earnings beat estimates revenue climbs 59 percent as stock gains Is Humacyte HUMA stock reflecting its growth potential Momentum Building 20260418 Is ORIX IX stock approaching a breakout zone ORIX Corp ADS posts 327 EPS beat topping estimates What NICE Ltd NICE does that makes it resilient Nudges Down 20260507 What is pushing Global GIC stock higher Q4 1999 EPS Beats Forecasts Is Wixcom WIX Stock a LongTerm Buy Smart Money Outflows 20260416 The balance sheet strength behind Athene Pfd D ATHD results ATHD Athene Pfd D Declares Quarterly Distribution STE STERIS plc drops 114 after narrow Q1 2026 EPS miss against analyst consensus estimates Why NextTrip NTRP could be the anchor your portfolio needs In Focus 20260508 BioLife BLFS smashes Q1 estimates with 96 EPS surprise driving 63 stock jump CINF Cincy Fin Q1 2026 EPS outpaces analyst forecasts stock notches modest daily gain after results release The MA impact hidden in Vornado VNOO earnings RAAQ Real Asset lays out new multimarket real estate acquisition goals in latest quarterly earnings release GDO Western reports no publicly disclosed quarterly EPS or revenue metrics in its latest earnings filing Merck Co Inc MRK Implications of Partner AstraZenecas Q1 2026 Earnings Beat for Oncology Portfolio Trajectory Consumer Sentiment Slumps Yet Retail Sales Climb How Long Can the Divergence Persist X3 XCBE Stock Steady at 991 Support at 941 20260515 Prime Medicine PRME Q1 2026 Disappoints EPS 028 Below 026 Views The Federal Reserve Is Quickly Running Out of Reasons to Cut Interest Rates Japans Horse Racing Industry Accelerates Digital Transformation From Singapore to Brussels World Leaders Cautiously Eye TrumpXi Summit Implications USChina Trade Relations Security Expert Says China Now Faces US as a Peer Amid Tariff Standoff Whats Next for Newbridge NBRGU at 997 20260518 April Jobs Report Surprises to the Upside 115K New Positions Added Protagonist Therapeutics PTGX Q1 2026 Earnings Why the Beat Matters IBF Launches AI Finance Training Programme for Undergraduates in Singapore Imperial IMPPP Crushes Q4 2025 Estimates EPS 035 Tops Views IRSA IRS Rallies 434 as Bulls Target 1465 20260518 Eikon Therapeutics EIKN Q1 2026 Disappoints EPS 246 Below 178 Views